Derya Goksu Fidan

Derya Goksu Fidan

Auto-generated profile, based on publicly available information

Derya Goksu Fidan

School of Medicine, Koc University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2025 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
SASama Mahmoud Abdel-Rahman
Sama Mahmoud Abdel-Rahman
LOLasin Ozbek
Lasin Ozbek
ANArif E. Narin
Arif E. Narin
DFDerya G. Fidan
Derya G. Fidan
ZYZeynep Y. Yilmaz
Zeynep Y. Yilmaz
MKMehmet Kanbay
Mehmet Kanbay

21 May 2025 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
LÖLaşin Özbek
Laşin Özbek
Mustafa GüldanMustafa Güldan
Mustafa Güldan
DFDerya G. Fidan
Derya G. Fidan
SASama M Abdel-Rahman
Sama M Abdel-Rahman
MKMehmet Kanbay
Mehmet Kanbay

30 April 2026 in Calcified Tissue International
Verified
Journal Article
Open access
PDF file
Mustafa GüldanMustafa Güldan
Mustafa Güldan
LÖLaşin Özbek
Laşin Özbek
DFDerya G. Fidan
Derya G. Fidan
ANArif E. Narin
Arif E. Narin
DHDitte Hansen
Ditte Hansen
MKMehmet Kanbay
Mehmet Kanbay
Although α-Klotho has gained attention as a promising biomarker of aging, its association with frailty and broader aging-related outcomes beyond chronic kidney disease–mineral and bone disorder remains incompletely characterized. This systematic review and meta-analysis aimed to investigate the association between circulating α-Klotho levels and aging-related outcomes, including frailty, effects of physical activity and exercise interventions, body composition, cognitive and neuropsychiatric status, sarcopenia, and bone mineral density (BMD). A comprehensive literature search was performed across multiple electronic databases, including Ovid MEDLINE, Web of Science, Scopus, PubMed, and the Cochrane Library, to identify relevant studies published up to April 30, 2025. Pooled analyses were conducted using random-effects models, with effect estimates synthesized as mean differences, odds ratios, or correlation coefficients, and heterogeneity assessed using the I 2 statistic. Risk of bias was assessed using design-specific tools, including the Newcastle–Ottawa Scale, the Risk of Bias 2 tool (RoB2) of the Cochrane collaboration, and the Joanna Briggs Institute (JBI) checklists. A total of 109 studies met the inclusion criteria and were included. In our meta-analysis, higher circulating α-Klotho levels were significantly associated with lower odds of frailty (OR = 0.61, 95% CI: 0.49, 0.77; p < 0.0001, I 2 = 0%). Exercise interventions increased circulating α-Klotho (95% CI: 93.93, 261.73, p < 0.0001; I 2 = 89%), but habitual physical activity showed no significant effect on α-Klotho compared to inactive controls ( p = 0.25; I 2 = 100%). Lower circulating α-Klotho levels were observed in individuals with osteoporosis compared with those with normal BMD (95% CI: − 114.98, − 25.49; p = 0.002) and in individuals with osteopenia compared with those with normal BMD (95% CI: − 123.22, − 0.74; p = 0.05), and were associated with fractures. Based on qualitative synthesis, circulating α-Klotho levels were positively associated with multiple physical function outcomes, including grip strength, short physical performance battery scores, and sit-to-stand performance, with mixed findings for gait speed and the 6-min walk test. Circulating α-Klotho appears to be a promising biomarker for frailty, physical function, and bone health in aging; however, evidence for cognitive outcomes remains limited and inconsistent. Substantial heterogeneity and the observational nature of most studies highlight the need for more standardized and longitudinal research. Graphical abstract

5 May 2026 in Cornea
Verified
Journal Article
Closed access
LSLeyla Yavuz Saricay
Leyla Yavuz Saricay
DFDerya Goksu Fidan
Derya Goksu Fidan
YFYilin Feng
Yilin Feng
GHGena Heidary
Gena Heidary
IMIason S. Mantagos
Iason S. Mantagos
TDThomas H. Dohlman
Thomas H. Dohlman
Purpose: To evaluate the effects of topical recombinant human nerve growth factor (rhNGF) in pediatric neurotrophic keratopathy (NK), with specific attention to corneal opacities, amblyopia, and visual outcomes. Methods: This retrospective study included 10 pediatric patients with NK refractory to conventional therapy who received topical rhNGF for 8 weeks. The cohort had complex multisystem comorbidities and frequently required bedside examinations with limited cooperation; therefore, standardized imaging, quantitative grading, and clinic-based photography were often not feasible. Results: Mean age was 5.1 ± 4.8 years, and 80% of patients were within the amblyogenic period. Mean follow-up was 71.7 ± 45.6 weeks. All patients presented with persistent epithelial defects and corneal opacities, central in 80% of cases. Baseline best-corrected visual acuity was 0.75 ± 0.23 logMAR. Complete epithelial healing was achieved in 9 of 10 patients (90%), with clinician-assessed qualitative improvement in corneal opacity appearance in 6 patients (60%) within 8 weeks. Baseline best-corrected visual acuity did not significantly improve at week 8 or at final follow-up. Six patients demonstrated asymmetric astigmatism greater than +1.50 diopters. One patient with advanced stage 3 NK did not achieve epithelial healing and had limited follow-up because of international referral. Conclusions: Topical rhNGF was effective and well tolerated in pediatric NK, producing rapid epithelial healing and qualitative improvement in corneal opacity appearance. Limited visual recovery likely reflects preexisting central stromal scarring and amblyopia, emphasizing the importance of early NK recognition and timely rhNGF initiation to preserve visual potential during childhood visual development and long-term clinical decision making globally care.

15 May 2026 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Open access
NSNurgül Samancı
Nurgül Samancı
AŞAyça Şahin
Ayça Şahin
YYYesim Yildiz
Yesim Yildiz
ECEmrah Celtikci
Emrah Celtikci
MŞMuammer Melih Şahin
Muammer Melih Şahin
KÇKayhan Çağlar
Kayhan Çağlar
Background: Candida meningitis is a rare but life-threatening infection, most commonly caused by Candida albicans . Candida dubliniensis , despite its close phenotypic similarity to C. albicans , is an uncommon cause of central nervous system (CNS) infections, with limited data available. To date, only 12 cases of C. dubliniensis meningitis have been reported worldwide. This study presents the 13th documented case and the first reported from Türkiye, together with a systematic review of the literature. Case presentation: A 44-year-old immunocompetent male developed meningitis caused by C. dubliniensis following subtotal resection of a clival meningioma. The diagnosis was established through fungal culture, MALDI-TOF MS, and ITS region DNA sequencing. The isolate was deposited in GenBank (accession number PV088619). Antifungal therapy with fluconazole was initiated based on susceptibility results. Despite appropriate antifungal management, the patient developed secondary Klebsiella pneumoniae sepsis and subsequently died, highlighting the complexity and high mortality risk associated with post-neurosurgical fungal CNS infections. Methods: A systematic review was conducted according to PRISMA guidelines using PubMed and Web of Science databases, including studies published up to February 2025. Search terms included “ Candida dubliniensis ” and “meningitis.” Only microbiologically confirmed cases with individual patient data were included. Studies older than 25 years or lacking sufficient diagnostic detail were excluded. Results and conclusion: Thirteen cases were identified. Most patients were immunocompetent, and infections were frequently acquired outside neurosurgical settings. Mortality was reported in four cases. These findings emphasize the extreme rarity of C. dubliniensis meningitis and underscore the importance of early species-level identification strategies.

30 July 2026 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
KEKübra Evren
Kübra Evren
FDFunda Demi̇r
Funda Demi̇r
MYMelek Yaman
Melek Yaman
ÖTÖzlem Güzel Tunçcan
Özlem Güzel Tunçcan
HTHasan Tezer
Hasan Tezer
GBGülendam Bozdayi
Gülendam Bozdayi